Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshiya Tsunoda is active.

Publication


Featured researches published by Yoshiya Tsunoda.


Oncology Reports | 2013

Prevalence of underlying lung disease in smokers with epidermal growth factor receptor-mutant lung cancer

Akimasa Sekine; Katsumi Tamura; Hiroaki Satoh; Tomoaki Tanaka; Yoshiya Tsunoda; Toru Tanaka; Hiroyuki Takoi; Shih-Yuan Lin; Yohei Yatagai; Toshinori Hashizume; Kenji Hayasihara; Takefumi Saito

The prevalence of underlying lung diseases, such as emphysema and interstitial lung disease in smokers with epidermal growth factor receptor (EGFR)-mutant lung cancer remains unclear. This study aimed to clarify the correlation between the EGFR mutation status and the prevalence of underlying lung disease in smokers with lung cancer. A total of 88 consecutive smokers with non-small cell or non-squamous cell lung cancer who underwent surgical resection at our hospital from January 2007 through December 2010 were included in this study. The patients were divided into two groups on the basis of the EGFR mutation status: the mutation-positive group (n=19) and the wild-type group (n=69). The results of radiographic assessment via computed tomography (CT) and pulmonary function analysis were compared between the two groups. In the radiological evaluation, CT images at three levels were evaluated by two reviewers. Radiographic assessment revealed that the mutation-positive group tended to have milder emphysematous changes and a lower prevalence of interstitial changes compared with the wild-type group (P=0.13, 0.06). When the analysis was limited to the ipsilateral lung at the nearest CT level to the tumor, emphysematous changes were found to be less common in the mutation-positive group (P=0.02). The prevalence of the emphysematous and/or interstitial changes in the ipsilateral lung at the nearest CT level to the tumor was lower in the mutation-positive group compared to the wild-type group (P=0.005). In the pulmonary function test, the results were comparable between the two groups. In conclusion, according to our results, EGFR-mutant lung cancer was commonly observed in the areas where emphysematous and interstitial changes were absent. EGFR-mutant lung cancer may develop in radiographically normal areas of the lungs, even in smokers. It would be of importance to evaluate the EGFR mutation status in patients with no emphysematous or interstitial changes in the ipsilateral lung near the tumor, regardless of their smoking history. These results should be confirmed in a future prospective study.


Internal Medicine | 2015

Central nervous system manifestations of tuberculosis-associated immune reconstitution inflammatory syndrome during adalimumab therapy: a case report and review of the literature.

Toru Tanaka; Akimasa Sekine; Yoshiya Tsunoda; Hiroyuki Takoi; Shin-Yuan Lin; Yohei Yatagai; Kenji Hayasihara; Takefumi Saito

A 64-year-old neurologically asymptomatic woman with rheumatoid arthritis who was treated with the tumor necrosis factor (TNF)-α antagonist adalimumab developed disseminated tuberculosis (TB). After receiving anti-TB therapy and discontinuing adalimumab, she exhibited paradoxical worsening due to immune reconstitution inflammatory syndrome (IRIS) with the appearance of meningitis and brain tuberculomas. This case indicates that continuing anti-TNF therapy may be necessary to prevent IRIS in patients who develop TB, particularly disseminated TB, during the course of anti-TNF therapy. In addition, careful screening for central nervous system (CNS) TB should be performed prior to the initiation of therapy, as even neurologically asymptomatic patients can develop CNS manifestations of IRIS.


Life Sciences | 2016

Landiolol hydrochloride ameliorates acute lung injury in a rat model of early sepsis through the suppression of elevated levels of pulmonary endothelin-1

Yujiro Matsuishi; Subrina Jesmin; Satoru Kawano; Sakuramoto Hideaki; Nobutake Shimojo; Chishimba Nathan Mowa; Shila Akhtar; Sohel Zaedi; Tanzila Khatun; Yoshiya Tsunoda; Takumi Kiwamoto; Nobuyuki Hizawa; Yoshiaki Inoue; Taro Mizutani

Among the dysfunctions and pathologies associated with sepsis, the underlying molecular mechanisms of sepsis-induced acute lung injury (ALI) are poorly understood. Endothelin (ET)-1, a potent vasoconstrictor and pro-inflammatory peptide, is known to be involved in the pathogenesis of ALI in a rat model of sepsis. Here, we investigated whether landiolol hydrochloride, an ultra-short-acting β-blocker, plays a crucial role in ameliorating and attenuating LPS-induced ALI through modulation of the ET-1 system. Male Wistar rats at 8weeks of age were administered with either saline or lipopolysaccharide (LPS) for three hours (3h) and some of the LPS-administered rats were continuously treated with landiolol for 3h. ALI was induced by LPS, including levels of both circulatory and pulmonary TNF-α and IL-6 but [PaO2] was significantly decreased. LPS also induced a significant increase in levels of pulmonary ET-1 and ET-A receptor, but levels of ET-B receptor, which has vasodilating effects, were remarkably diminished. Further, LPS administration upregulated the pulmonary expression of HIF-1α. Finally, the treatment of LPS-administered rats with landiolol for 3h ameliorated and prevented ALI, normalized the altered levels of pulmonary ET-1 and ET-A receptors. Landiolol also induced significant down-regulation of ET-B receptor in lung tissues in the early hours (phase) of sepsis. However, Landiolol treatment had no effect on the up-regulated inflammatory mediators (TNF-α, IL-6) in both plasma and lung tissues during sepsis, and expression of pulmonary HIF-1α also remained unchanged after landiolol treatment. Collectively, these data led us to conclude that landiolol may ameliorate sepsis-induced ALI via the pulmonary ET system.


Respiratory investigation | 2012

Two cases of tuberculosis with multiple drug hypersensitivity after drug-induced hypersensitivity syndrome

Akimasa Sekine; Takefumi Saito; Shusaku Ito; Yoshiya Tsunoda; Yuki Sumazaki; Toru Tanaka; Hiroyuki Takoi; Shih-Yuan Lin; Yohei Yatagai; Kenji Hayasihara

Here, we report 2 cases of drug-induced hypersensitivity syndrome (DIHS) caused by salazosulfapyridine and allopurinol during tuberculosis treatment. Both patients also developed multiple drug hypersensitivity (MDH) to several antituberculosis drugs that were used at around the period of DIHS onset, and thus, the treatment could not be successfully completed. Our cases show that MDH can easily occur after development of DIHS. Considering that treatment for tuberculosis requires long-term management with several drugs, it is important to refrain from administering drugs that can cause DIHS during tuberculosis treatment.


Clinical Respiratory Journal | 2017

Limited Value of Transbronchial Lung Biopsy for Diagnosing Mycobacterium avium Complex Lung Disease

Akimasa Sekine; Takefumi Saito; Hiroaki Satoh; Yukio Morishita; Yoshiya Tsunoda; Toru Tanaka; Yohei Yatagai; Shih-Yuen Lin; Kunihiko Miyazaki; Yukiko Miura; Kenji Hayashihara

It remains unclear whether transbronchial lung biopsy (TBLB) is useful for diagnosing Mycobacterium avium complex (MAC) lung disease.


Case Reports | 2013

Spontaneous coronary artery dissection in a patient with bacterial meningitis

Kensuke Kinoshita; Yoshiya Tsunoda; Shigeyuki Watanabe; Yasuharu Tokuda

A 40-year-old man was admitted to our hospital because of the acute onset of fever and headache, which were attributed to bacterial meningitis. Antibiotic treatment was initiated and his condition gradually improved. On day 5 after admission, immediately after masturbation, he developed abrupt onset of severe chest pain and cold sweat and the ECG suggested acute anterior myocardial infarction. Immediate coronary angiography revealed spontaneous dissection of the left anterior descending artery. After conservative management, his cardiac function improved. Acute coronary syndrome may be rarely caused by spontaneous coronary artery dissection. Sepsis was considered as a probable trigger for spontaneous coronary artery dissection, possibly through vascular damage from increased nitric oxide and sympathetic nervous over-activation.


Free Radical Biology and Medicine | 2018

Sulforaphane ameliorates steroid insensitivity through an Nrf2-dependent pathway in cigarette smoke-exposed asthmatic mice

Hirofumi Sakurai; Yuko Morishima; Yukio Ishii; Kazufumi Yoshida; Masayuki Nakajima; Yoshiya Tsunoda; Shih-Yuan Hayashi; Takumi Kiwamoto; Yosuke Matsuno; Mio Kawaguchi; Masayuki Yamamoto; Nobuyuki Hizawa

&NA; Oxidative stress induced by cigarette smoke and other environmental pollutants contributes to refractory asthma. To better understand the role of smoking in asthma, we investigated the effects of cigarette smoke on allergic airway responses in mice and examined expression of nuclear factor‐E2‐related factor‐2 (Nrf2) and its downstream factors, because Nrf2 is known to play a pivotal role in antioxidant responses. OVA‐sensitized and challenged BALB/c mice were exposed to cigarette smoke and then treated with dexamethasone, sulforaphane (an activator of Nrf2), or their combination. Upon exposure to cigarette smoke, Nrf2 and associated transcripts were upregulated in response to oxidative stress, and asthmatic responses were steroid resistant. In OVA‐sensitized and challenged mice exposed to cigarette smoke and treated with sulforaphane, Nrf2‐mediated antioxidant responses were upregulated to a greater extent, and steroid sensitivity of asthmatic responses was restored. Moreover, the expression and activity of histone deacetylase 2 (HDAC2), a key regulator of steroid responsiveness, was reduced in mice exposed to cigarette smoke, but restored by sulforaphane treatment. No effects of sulforaphane were observed in Nrf2‐deficient mice. These findings indicate that cigarette smoke induces steroid unresponsiveness in asthmatic airways, and that sulforaphane restores steroid sensitivity via upregulation of Nrf2 and enhancement of HDAC2 expression and activity. Thus, Nrf2 may serve as a potential molecular target for cigarette smoke‐related refractory asthma resistant to steroid therapy. Graphical abstract Figure. No caption available. HighlightsCigarette smoking induces steroid insensitivity and raises refractory asthma risk.Smoke exposure‐induced oxidant/antioxidant imbalance inhibits HDAC2 activity.Oxidant/antioxidant imbalance contributes to steroid resistance in asthmatic mice.HDAC2 activity is enhanced by sulforaphane via Nrf2 activation.Nrf2 may be a target for restoring steroid sensitivity in smoking‐related asthma.


Molecular and Clinical Oncology | 2017

Paraneoplastic limbic encephalitis with late‑onset magnetic resonance imaging findings: A case report

Yoshiya Tsunoda; Takumi Kiwamoto; Shinsuke Homma; Yuuki Yabuuchi; Haruna Kitazawa; Toshihiro Shiozawa; Kensuke Nakazawa; Takashi Hosaka; Kazuhiro Ishii; Akiko Ishii; Akira Tamaoka; Nobuyuki Hizawa

Paraneoplastic limbic encephalitis (PLE), a paraneoplastic neurological syndrome (PNS), is a rare nervous system disorder that results from the indirect effects of tumors and is commonly associated with small-cell lung cancer (SCLC). Previous studies have reported that magnetic resonance imaging (MRI) may be useful for diagnosing LE. Temporal lobe abnormalities are observed using T2-weighted and fluid-attenuated inversion recovery sequences; however, such abnormalities are detected in only 60% of patients with PLE. The present study describes a case of PLE associated with SCLC, in which LE was observed using MRI 26 days after the first convulsive seizure. Although the serum and cerebrospinal fluid analyses for onconeural antibodies were negative, the findings of this case indicate that PLE should be considered in the differential diagnosis, and that repeated brain MRI may be more helpful for diagnosis, as the brain MRI findings may be normal during the early stages of PLE.


Sarcoidosis Vasculitis and Diffuse Lung Diseases | 2014

Clinical experience with pirfenidone in five patients with scleroderma-related interstitial lung disease.

Yukiko Miura; Takefumi Saito; Kazutaka Fujita; Toru Tanaka; Yoshiya Tsunoda; Arata Azuma; Takahito Nei; Yohei Yatagai; Shigen Rin; Akimasa Sekine; Kenji Hayashihara


European Respiratory Journal | 2014

Clinical effect of pirfenidone on incidence of lung carcinoma in chronic interstitial pneumonia

Yukiko Miura; Takefumi Saito; Yoshiya Tsunoda; Toru Tanaka; Hiroyuki Takoi; Yohei Yatagai; Shih-Yuan Lin; Akimasa Sekine; Kenji Hayashihara; Minoru Inomata; Takahito Nei; Yoshinobu Saito; Akihiko Gemma; Arata Azuma

Collaboration


Dive into the Yoshiya Tsunoda's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge